Unilateral multicystic dysplastic kidney in infants exposed to antiepileptic drugs during pregnancy

Pediatric Nephrology

Volumn 22, Issue 7, 2007, Pages 1054-1057

  Carta, Maurizio ^a   Cimador, Marcello ^a   Giuffrè, Mario ^a   Sergio, Maria ^a   Pace, Maria Rita ^a   Grazia, Enrico ^a   Corsello, Giovanni ^a  

^a UNIVERSITY OF PALERMO   (Italy)

Author keywords

Antiepileptic drugs; Infant; Major congenital anomalies; Multicystic dysplastic kidney

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; FOLIC ACID; PHENOBARBITAL;

AMNIOCENTESIS; ARTICLE; CASE REPORT; CESAREAN SECTION; COMPUTER ASSISTED TOMOGRAPHY; ECHOGRAPHY; EPICANTHUS; EPILEPSY; FACE DYSMORPHIA; FEMALE; FIRST TRIMESTER PREGNANCY; FOLLOW UP; HUMAN; HYPERTELORISM; KIDNEY AGENESIS; KIDNEY HYPERTROPHY; LOW DRUG DOSE; MICTURITION CYSTOURETHROGRAPHY; MULTICYSTIC DYSPLASTIC KIDNEY; NEWBORN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; SCINTISCANNING; TERATOGENICITY; VESICOURETERAL REFLUX;

ANTICONVULSANTS; CARBAMAZEPINE; EPILEPSY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; MULTICYSTIC DYSPLASTIC KIDNEY; PHENOBARBITAL; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; TIME FACTORS; TREATMENT OUTCOME; ULTRASONOGRAPHY, PRENATAL;

EID: 34249983623     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-007-0446-x     Document Type: Article

References (21)

1. Holmes LB, Harvey EA, Coull BA, Huntington KB, Khoshbin S, Hayes AM, Ryan LM (2001) The teratogenicity of anticonvulsant drugs. N Eng J Med 344:1132-1138
2. Pennel PB (2004) Pregnancy in women who have epilepsy. Neurol Clin 22:799-820
3. Fried S, Kozer E, Nulman I, Einarson TR, Koren G (2004) Malformation rates in children of women with untreated epilepsy; a meta-analysis. Drug Saf 27:197-202
4. Canger R, Battino D, Canevini MP, Fumarola C, Guidolin L, Vignoli A, Mamoli D, Palmieri C, Molteni F, Granata T, Hassibi P, Zamperini P, Pardi G, Avanzino G (1999) Malformations in offspring of women with epilepsy: A prospective study. Epilepsia 40:1231-1236
5. Fairgrieve SD, Jackson M, Jonas P, Walshaw D, White K, Montgomery TL, Burn J, Lynch SA (2000) Population based, prospective study of the care of woman with epilepsy in pregnancy. BMJ 321:674-675
6. Yerby MS (2001) The use of anticonvulsants during pregnancy. Semin Perinatol 25:153-158
7. Stumpf DA, Frost M (1978) Seizures, anticonvulsants, and pregnancy. Am J Dis Child 132:746-748
8. Samren EB, van Duijn CM, Christiaens GCML, Hofman A, Lindhout D (1999) Antiepileptic drug regimens and major congenital abnormalities in the offspring. Ann Neurol 46:739-746
9. Wide K, Winbladh B, Kallen B (2004) Major malformations in infants exposed to antiepileptic drugs in utero, with emphasis on carbamazepin and valproic acid: A nation-wide, population-based register study. Acta Pediatr 93:174-176
10. Matalon S, Schechtman S, Godzweig G, Ornoy A (2002) The teratogenic effect of carbamazepine: A meta-analysis of 1255 exposures. Reprod Toxicol 16:9-17
11. Janz D (1994) Are anti epileptic drugs harmful when taken during pregnancy? J Perinat Med 22:367-375
12. Lindhout D, Hoppener RJ, Meinardi H (1984) Teratogenicity of antiepileptic drug combinations with special emphasis on epoxidation (of carbamazepine). Epilepsia 25:77-83
13. Arpino C, Brescianini S, Robert E, Castilla EE, Cocchi G, Cornel MC, de Vigan C, Lancaster PA, Merlob P, Sumiyoshi Y, Zampino G, Renzi C, Rosano A, Mastroiacovo P (2000) Teratogenic effects of antiepileptic drugs: Use of an International Database on Malformations and Drug Exposure (MADRE). Epilepsia 41:1436-1443
14. Hernandez-Diaz S, Werler MM, Walker AM, Allen A (2000) Folic acid antagonists during pregnancy and the risk of birth defects. N Eng J Med 343:1608-1614
15. Pope JC, Brock JW, Adams MC, Douglas Stephens F, Ichikawa I (1999) How they begin and how they end: Classic and new theories for the development and deterioration of congenital anomalies of the kidney and urinary tract, CAKUT. J Am Soc Nephrol 10:2018-2028
16. Chandler D, El-Naggar AK, Brisbay S, Redline RW, McDonnel TJ (1994) Apoptosis and expression of the bcl-2 proto-oncogene in the fetal and adult human kidney: Evidence for the contribution of bcl-2 expression to renal carcinogenesis. Human Pathol 25:789-796
17. Trudel M, Lanoix J, Barisoni L, Bloudin M, Desforges M, L'Italien C, D'Agati V (1997) C-MYC-induced apoptosis in polycystic kidney disease is Bcl-2 and p53 independent. J Exp Med 186:1873-1884
18. Sorenson CM, Padanilam BJ, Hammerman MR (1996) Abnormal postpartum renal development and cystogenesis in the bcl-2 (--/--) mouse. Am J Physiol 271:F184-F193
19. Winyard PJD, Risdon RA, Sams VR, Dressler GR, Woolf AS (1996) The PAX2 transcription factor is expressed in cystic and hyperprofilerative dysplastic epithelia in human kidney malformations. J Clin Invest 98:451-459
20. Worner W, Schrenk D (1996) Influence of liver tumor promoters on apoptosis in rat hepatocytes induced by 2-acetylaminofluorene, ultraviolet light, or transforming growth factor beta 1. Cancer Res 56:1272-1278
21. Sanders S, Thorgeirsson SS (1999) Phenobarbital promotes liver growth in c-myc/TGF-a transgenic mice by inducing hypertrophy and inhibiting apoptosis. Carcinogenesis 20:41-49